Clinical Trials Sponsored by Sichuan Cancer Hospital & Institute

Total 3929 results

Shandong Cancer Hospital and Institute

Recruiting

Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy

Limited Stage Small Cell Lung Cancer

China
Peking University Cancer Hospital & Institute

Recruiting

Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer

Colorectal Cancer | Positron-Emission Tomography | Tumor, Solid

China
Peking University Cancer Hospital & Institute

Recruiting

The Role of TCM on ERAS of Rectal Cancer Patients (RCT)

Rectal Cancer

China
Peking University Cancer Hospital & Institute

Not yet recruiting

To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency Ablation

Colorectal Cancer | Radiofrequency Ablation | Liver Metastasis | KRAS Gene | Safe Margin
Peking University Cancer Hospital & Institute

Recruiting

Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer (BJCC-R01)

Rectum Cancer

China
Shandong Cancer Hospital and Institute

Recruiting

Metabolomics Explores Biomarkers for Metastatic Breast Cancer

Breast Cancer

China
Shandong Cancer Hospital and Institute

Not yet recruiting

Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast Cancer

Metastatic Breast Cancer
Peking University Cancer Hospital & Institute

Recruiting

Study to Evaluate OrienX010 in Combination With JS001 in the Treatment of Stage IV (M1c) Liver Metastasis From Melanoma

Melanoma

China
Peking University Cancer Hospital & Institute

Recruiting

Toripalimab in Combination With Axitinib in Patients With Localized Mucosal Melanoma

Mucosal Melanoma

China
Shandong Cancer Hospital and Institute

Not yet recruiting

Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer

Metastatic Breast Cancer
Peking University Cancer Hospital & Institute

Recruiting

Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer (RESCUE-GC)

Gastric Cancer

China
Peking University Cancer Hospital & Institute

Active, not recruiting

[Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients

Prostate Cancer

China
Peking University Cancer Hospital & Institute

Enrolling by invitation

A Phase Ⅱ Trial of Neoadjuvant Toripalimab Plus Platinum-doublet Chemotherapy in Locally Advanced NSCLC.

Locally Advanced NSCLC

China
Peking University Cancer Hospital & Institute

Completed

Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients

Solid Tumor

China
Peking University Cancer Hospital & Institute

Completed

Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer

Rectal Cancer

China
Shandong Cancer Hospital and Institute

Unknown

Pyrotinib Combined With Trastuzumab And Chemotherapy in HER2-positive MBC

Metastatic Breast Cancer | HER2-positive Breast Cancer
Shandong Cancer Hospital and Institute

Unknown

Comparison Study of Different Tumor Biopsy Method for Sentinel Lymph Node Biopsy in Breast Cancer

Breast Cancer | Sentinel Lymph Node

China
Shandong Cancer Hospital and Institute

Unknown

A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-line Treatment

Non-Small-Cell Lung Cancer
Peking University Cancer Hospital & Institute

Unknown

Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen

Rectal Cancer

China
Shandong Cancer Hospital and Institute

Unknown

Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy

Lung Neoplasms | Esophagitis | Prevention & Control | Epigallocatechin Gallate
Shandong Cancer Hospital and Institute

Unknown

Study of Topically Applied Green Tea Extract for Radio Dermatitis and Radiation Mucositis

Epigallocatechin Gallate | Radiation Mucositis | Radio Dermatitis
Peking University Cancer Hospital & Institute

Unknown

A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer

Urothelial Carcinoma

China
Peking University Cancer Hospital & Institute

Unknown

Performance of White Light, NBI and Iodine Staining Endoscopy in the Diagnosis of Esophageal Lesions

Esophageal Squamous Cell Carcinoma | Mild Dysplasia of Esophagus | Moderate Dysplasia of Esophagus | Severe Dysplasia of Esophagus | Carcinoma in Situ of Esophagus

China
Shandong Cancer Hospital and Institute

Unknown

Temperature and Injury in Radiotherapy Radiation Skin Injury

Breast Neoplasm Female | Radiation Toxicity
Peking University Cancer Hospital & Institute

Unknown

Nab-PCE vs PC for MM After Failure of Anti-PD-1

Advanced Melanoma

China
Shandong Cancer Hospital and Institute

Available

Oral Green Tea Extract for Small Cell Lung Cancer

Small Cell Lung Carcinoma

China
Shandong Cancer Hospital and Institute

Unknown

Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients

Carcinoma, Non-Small-Cell Lung

China
Shandong Cancer Hospital and Institute

Unknown

Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients (CRAGMOLC)

Carcinoma, Non-Small-Cell Lung

China
Shandong Cancer Hospital and Institute

Completed

Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive (IMSLNB-CANP)

Breast Cancer

China
Shandong Cancer Hospital and Institute

Withdrawn

Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node (Z0011-China)

Breast Cancer

China
Shandong Cancer Hospital and Institute

Completed

Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Negative (IMSLNB-EBCP)

Breast Cancer

China
Shandong Cancer Hospital and Institute

Completed

The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.

Cervical Cancer | Stomach Cancer | Breast Cancer | Esophageal Cancer | Non-small Cell Lung Cancer | Ovary Cancer | Malignancies

China
Peking University Cancer Hospital & Institute

Completed

Compare the Aesthetic Effect of Different Thyroidectomies

Differentiated Thyroid Carcinoma (DTC)
Peking University Cancer Hospital & Institute

Unknown

Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma

Melanoma

China
Peking University Cancer Hospital & Institute

Unknown

Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients

Metastatic Renal Cell Carcinoma

China
Peking University Cancer Hospital & Institute

Unknown

A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver Neoplasms

Liver Neoplasms

China
Peking University Cancer Hospital & Institute

Unknown

Blood Detection of EGFR Mutation For Iressa Treatment (Benefit)

Lung Adenocarcinoma

China
Peking University Cancer Hospital & Institute

Unknown

Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma

Lymphoma, Large B-Cell, Diffuse

China
Shandong Cancer Hospital and Institute

Unknown

Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive Patients

Chronic Hepatitis B | Dysplastic Nodule of Liver
Shandong Cancer Hospital and Institute

Unknown

A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma

Prosthesis Survival

China
Shandong Cancer Hospital and Institute

Unknown

A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma

Glioblastoma

China
Peking University Cancer Hospital & Institute

Unknown

A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients

Melanoma

China
Peking University Cancer Hospital & Institute

Completed

Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer

Breast Neoplasm | Drug Therapy | Polymorphism,Single Nucleotide

China
Peking University Cancer Hospital & Institute

Completed

Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC) (MBC)

Breast Neoplasms | Neoplasm Metastasis

China
Peking University Cancer Hospital & Institute

Completed

Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients (DC-CIK)

Breast Neoplasms | Neoplasm Metastasis

China
Peking University Cancer Hospital & Institute

Unknown

Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC)

Small Cell Lung Cancer Extensive Stage

China
Shandong Cancer Hospital and Institute

Unknown

Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer

Non Small Cell Lung Cancer

China
Shandong Cancer Hospital and Institute

Unknown

IMRT/Pemetrexed/Cisplatin in Esophageal Cancer

Esophageal Cancer

China
Shandong Cancer Hospital and Institute

Unknown

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma

Liver Diseases | Neoplasms by Histologic Type | Neoplasms by Site | Adenocarcinoma | Carcinoma | Neoplasms, Glandular and Epithelial | Digestive System Neoplasms | Carcinoma, Hepatocellular | Liver Neoplasms | HBV | PHENYTOIN/SORAFENIB [VA Drug Interaction] | DOXORUBICIN/TRASTUZUMAB [VA Drug Interaction]

China
Peking University Cancer Hospital & Institute

Unknown

Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)

Biliary Tract Cancer

China

Clinical Trials Sponsored by Sichuan Cancer Hospital & Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations